Market Cap 1.95B
Revenue (ttm) 63.72M
Net Income (ttm) -193.51M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -303.69%
Debt to Equity Ratio 0.27
Volume 6,868,200
Avg Vol 4,300,230
Day's Range N/A - N/A
Shares Out 213.05M
Stochastic %K 5%
Beta 0.93
Analysts Strong Sell
Price Target $23.38

Company Profile

Ocular Therapeutix, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in the United States. The company markets DEXTENZA, a dexamethasone ophthalmic insert to treat post-surgical ocular inflammation and pain following ophthalmic surgery, as well as allergic conjunctivitis. It is also developing AXPAXLI, an axitinib intravitreal hydrogel that i...

Industry: Biotechnology
Sector: Healthcare
Phone: 781 357 4000
Fax: 781 275 7562
Address:
15 Crosby Drive, Bedford, United States
Kynoch
Kynoch Feb. 4 at 1:54 PM
$OCUL https://seekingalpha.com/article/4865639-ocular-therapeutix-why-sol-1-trial-outcome-is-likely-positive
0 · Reply
ConvexityX
ConvexityX Feb. 4 at 1:38 PM
$OCUL is an ophthalmic biotech with a commercial product for dry eye disease; its growth depends on gaining formulary access and market share against entrenched competitors.
0 · Reply
rizzato
rizzato Feb. 4 at 1:36 PM
$OCUL I think we should clear even If I also hate that drop that is for sure note sue to a dad data news coming. Nobody know the data result it is illegal and for sure main institution that added more with the capital raise at higher price and are adding more during that drop are still in Said that That share price us a really bull shit
1 · Reply
MaxKlim
MaxKlim Feb. 4 at 12:00 PM
$OCUL https://fintel.io/so/us/ocul calm down, don't panic a search for weak hands is underway
1 · Reply
lilcapman
lilcapman Feb. 4 at 11:51 AM
$OCUL Tick tick tick tick tick tick tick tick tick
1 · Reply
Dukpoo
Dukpoo Feb. 4 at 11:50 AM
$OCUL mad at myself for buying this, anybody still in?
2 · Reply
MaxKlim
MaxKlim Feb. 4 at 9:57 AM
$OCUL I returned here after 5 years, expecting profit 10 000- 8,8$ patience to all bulls In God we trust 🙏🙏🙏
0 · Reply
MaxKlim
MaxKlim Feb. 4 at 7:59 AM
0 · Reply
Donaut
Donaut Feb. 4 at 1:46 AM
$OCUL Pravin won't let us down
1 · Reply
WarrenDouglasTrader
WarrenDouglasTrader Feb. 4 at 1:18 AM
$OCUL BRUTAL. $8.50 is a key level.
0 · Reply
Latest News on OCUL
Ocular Therapeutix, Inc. (OCUL) Analyst/Investor Day Transcript

Oct 1, 2025, 4:22 AM EDT - 4 months ago

Ocular Therapeutix, Inc. (OCUL) Analyst/Investor Day Transcript


Ocular Is Now Thoroughly Derisked

Dec 30, 2024, 12:16 PM EST - 1 year ago

Ocular Is Now Thoroughly Derisked


Ocular Therapeutix™ Reports Second Quarter 2024 Results

Aug 7, 2024, 7:10 AM EDT - 1 year ago

Ocular Therapeutix™ Reports Second Quarter 2024 Results


Ocular Therapeutix® to Host Investor Day on June 13, 2024

Jun 5, 2024, 7:30 AM EDT - 1 year ago

Ocular Therapeutix® to Host Investor Day on June 13, 2024


Ocular Therapeutix™ Reports First Quarter 2024 Results

May 7, 2024, 4:05 PM EDT - 1 year ago

Ocular Therapeutix™ Reports First Quarter 2024 Results


Kynoch
Kynoch Feb. 4 at 1:54 PM
$OCUL https://seekingalpha.com/article/4865639-ocular-therapeutix-why-sol-1-trial-outcome-is-likely-positive
0 · Reply
ConvexityX
ConvexityX Feb. 4 at 1:38 PM
$OCUL is an ophthalmic biotech with a commercial product for dry eye disease; its growth depends on gaining formulary access and market share against entrenched competitors.
0 · Reply
rizzato
rizzato Feb. 4 at 1:36 PM
$OCUL I think we should clear even If I also hate that drop that is for sure note sue to a dad data news coming. Nobody know the data result it is illegal and for sure main institution that added more with the capital raise at higher price and are adding more during that drop are still in Said that That share price us a really bull shit
1 · Reply
MaxKlim
MaxKlim Feb. 4 at 12:00 PM
$OCUL https://fintel.io/so/us/ocul calm down, don't panic a search for weak hands is underway
1 · Reply
lilcapman
lilcapman Feb. 4 at 11:51 AM
$OCUL Tick tick tick tick tick tick tick tick tick
1 · Reply
Dukpoo
Dukpoo Feb. 4 at 11:50 AM
$OCUL mad at myself for buying this, anybody still in?
2 · Reply
MaxKlim
MaxKlim Feb. 4 at 9:57 AM
$OCUL I returned here after 5 years, expecting profit 10 000- 8,8$ patience to all bulls In God we trust 🙏🙏🙏
0 · Reply
MaxKlim
MaxKlim Feb. 4 at 7:59 AM
0 · Reply
Donaut
Donaut Feb. 4 at 1:46 AM
$OCUL Pravin won't let us down
1 · Reply
WarrenDouglasTrader
WarrenDouglasTrader Feb. 4 at 1:18 AM
$OCUL BRUTAL. $8.50 is a key level.
0 · Reply
Donaut
Donaut Feb. 3 at 11:28 PM
$OCUL Awful, scary dumping This makes people hard
0 · Reply
HahaYouSUCK
HahaYouSUCK Feb. 3 at 11:08 PM
$OCUL cmon give us results
0 · Reply
StarLord13
StarLord13 Feb. 3 at 10:08 PM
$OCUL Jesus, needs a 50% run just to get back to last months SP.
0 · Reply
guidoriz
guidoriz Feb. 3 at 9:26 PM
$OCUL why they paid 400 million capital raise and are adding more during the drop? any idea?
1 · Reply
BigErvy
BigErvy Feb. 3 at 9:04 PM
$OCUL data may be released same time as earnings. Potential reward looking good for the risk at these prices.
0 · Reply
KimboIce
KimboIce Feb. 3 at 9:03 PM
$OCUL regardless of price drop , the MC is still $1.8 billion . Everyone has a grand conspiracy of recent SP drop. It could be as simple as the market is re-calibrating the value based on a small p.1 N prior to SOL-1 readout . Outside of DR funding , nothing has really changed data wise . I think previous high MC was due to more management huff and puff about how excellent things are going . Markets simply sniffed out the bullshit and waiting for hard data to justify high MC IMO.
1 · Reply
ChartSherpa
ChartSherpa Feb. 3 at 8:49 PM
$OCUL just want to point out that when $SNY acquired $PRVB in 2023, they also drove the price down by nearly 50% just before the announcement. Selling puts here
2 · Reply
nicky7
nicky7 Feb. 3 at 8:36 PM
$OCUL let’s gooooooooo
0 · Reply
ShortSuckieTuckie
ShortSuckieTuckie Feb. 3 at 8:12 PM
$OCUL I couldn't resist.... another 1,000 shares at $8.37
3 · Reply
BJM111
BJM111 Feb. 3 at 8:11 PM
I bought more $OCUL shares today. Unbelievable bargain down nearly 50 percent from recent high with no news and no change in thesis. I expect positive SOL1 results in the next few weeks.
0 · Reply
lilcapman
lilcapman Feb. 3 at 8:03 PM
$OCUL https://www.pharmalive.com/pharma-people-on-the-move-winter-2026-roundup/
0 · Reply
greensmell
greensmell Feb. 3 at 8:02 PM
$OCUL Entered a quite period in December for a Q1 readout while $GOSS CEO is out chilling at PVR (Jan 28-Feb 1) with data due in few weeks.😂 (from X @avidresearch)
0 · Reply